Prokarium is a clinical-stage biopharmaceutical company pioneering bacterial immunotherapies for the treatment of solid tumors, leveraging a proprietary strain of bacteria (ZH9) as a microbial immunotherapy platform
Prokarium is a clinical-stage biopharmaceutical company pioneering bacterial immunotherapies for the treatment of solid tumors, leveraging a proprietary strain of bacteria (ZH9) as a microbial immunotherapy platform.